NCT04701697View on ClinicalTrials.gov

Phase Ib of Recombinant Human Albumin Injection

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 15, 2020

Primary Completion Date

September 10, 2020

Study Completion Date

October 25, 2020

Conditions
Ascites
Interventions
DRUG

Recombinant Human Albumin Injection

Participants will receive Recombinant Human Albumin Injection of intravenous infusion

DRUG

HumanAlbumin

Participants will receive HumanAlbumin of intravenous infusion

Trial Locations (1)

130021

the first hospital of Jilin University, Changchun

All Listed Sponsors
lead

The First Hospital of Jilin University

OTHER

NCT04701697 - Phase Ib of Recombinant Human Albumin Injection | Biotech Hunter | Biotech Hunter